INTC vs TMO: Which Is the Better Buy?
Side-by-side comparison of Intel Corp. and Thermo Fisher Scientific Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-25.
Intel Corp. · Technology
$127.39
-8.4% upside to fair value
Low Conviction
Grade D
VS
Thermo Fisher Scientific Inc. · Healthcare
$658.32
+31.1% upside to fair value
Med Conviction
Grade B
High Quality
QuantHub Verdict
TMO has more upside to fair value
(+31.1%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
INTC |
TMO |
| Current Price |
$127.39 |
$658.32 |
| Fair Value Estimate |
$116.75 |
$863.34 |
| Upside to Fair Value |
-8.4%
|
+31.1%
|
| Market Cap |
$642.6B |
$244.7B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
185.2x
|
25.9x
|
| Price / Sales |
11.3x
|
5.3x
|
| Price / FCF |
229.7x
|
33.4x
|
| Revenue Growth YoY |
+25.4%
|
+10.5%
|
| Gross Margin |
38.9%
|
40.4%
|
| Operating Margin |
0.1%
|
17.7%
|
| Return on Equity |
-10.8%
|
13.4%
|
| Dividend Yield |
0% |
0.28% |
| FCF Yield |
0.44%
|
3.0%
|
| Analyst Consensus |
Hold
|
Strong Buy
|
Investment Thesis
Intel designs and manufactures CPUs, GPUs, networking silicon, and edge and data-center products across its Client Computing, Data Center and AI, and Intel Foundry segments, employing roughly 85,100 people under CEO Lip-Bu Tan. The business quality is currently low: TTM gross margin is 38.9%, TTM operating margin is 0.1%, TTM net margin is -19.8%, and ROE is -10.8%, so the company is not earning …
Thermo Fisher Scientific is a global life-sciences and laboratory-services platform spanning Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services, with recognized brands including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Patheon, and PPD, serving pharmaceutical, biotech, clinical, academic, and governme…
Accumulation Zones
| Metric |
INTC |
TMO |
| Zone Low |
$87.56 |
$647.50 |
| Zone High |
$99.24 |
$733.84 |
| In Buy Zone? |
No
|
Yes
|